Can LMWH improve the outcome of patients with inoperable stage III non-small cell lung cancer?

AIM OF THE STUDY: Lung cancer is the most common malignancy, accounting for one-third of all deaths from cancer. Some studies have shown that low molecular weight heparin (LMWH) significantly prolongs the survival of patients with non-small cell lung cancer (NSCLC). The aim of this study was to dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Kucukoner, Mehmet, Isikdogan, Abdurrahman, Kaplan, Muhammed Ali, Inal, Ali, Zinciroglu, S., Cit, Murtaza, Cil, Timucin, Karadayi, Bilgehan, Dirier, Ahmet, Yildiz, Ismail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2012
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687451/
https://www.ncbi.nlm.nih.gov/pubmed/23788920
http://dx.doi.org/10.5114/wo.2012.31771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687451/
https://www.ncbi.nlm.nih.gov/pubmed/23788920
http://dx.doi.org/10.5114/wo.2012.31771

Ejemplares similares